Showing results (241-250 of 510) with videos related to

Sort By:
Pageof 51
Immunotherapy|August 9, 2018
Intravenous immunoglobulin 10% in children with primary immunodeficiency diseasesHans D Ochs, Isaac Melamed, Michael Borte, et al.
Molecular Therapy. Methods & Clinical Development|October 27, 2021
Safety and efficacy of an engineered hepatotropic AAV gene therapy for ornithine transcarbamylase deficiency in cynomolgus monkeysJulien Baruteau, Sharon C Cunningham, Berna Seker Yilmaz, et al.
Scientific Reports|August 30, 2017
Erratum: Lentiviral vectors can be used for full-length dystrophin gene therapyJohn R Counsell, Zeinab Asgarian, Jinhong Meng, et al.
Scientific Reports|March 3, 2017
Lentiviral vectors can be used for full-length dystrophin gene therapyJohn R Counsell, Zeinab Asgarian, Jinhong Meng, et al.
Scientific Reports|March 18, 2017
Lentiviral vectors can be used for full-length dystrophin gene therapyJohn R Counsell, Zeinab Asgarian, Jinhong Meng, et al.
Cytotherapy|July 6, 2016
Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS prodigyUlrike Mock, Lauren Nickolay, Brian Philip, et al.
Journal of Clinical Immunology|April 28, 2007
Sequence analysis of TNFRSF13b, encoding TACI, in patients with systemic lupus erythematosusUlrich Salzer, Jennifer Birmelin, Chiara Bacchelli, et al.
Pageof 51